Synspira competitors and similar companiesClear all

Synspira's competitors and similar companies include ReCode Therapeutics, Sigilon, Rubius Therapeutics and Atara Biotherapeutics.
Synspira
Synspira
Synspira Therapeutics is a company providing treatment for people with cystic fibrosis and other rare diseases.
ReCode Therapeutics
ReCode Therapeutics
ReCode Therapeutics is a company developing non-viral nanoparticles for delivery of diverse RNA- and protein-based therapeutics to targeted tissues, and tRNA NanoCorrectors.
Sigilon
Sigilon
Sigilon is a biotechnology company developing functional cures for patients with chronic diseases.
Rubius Therapeutics
Rubius Therapeutics
Rubius is developing a new class of drugs, Red-Cell Therapeutics™.
Atara Biotherapeutics
Atara Biotherapeutics
Atara Biotherapeutics is a drug development company focused on developing innovative therapies for patients with debilitating diseases.
Founding Date
Founding Date
2017
Founding Date
2015
Founding Date
2015
Founding Date
2013
Founding Date
2012
Type
Type
Private
Type
Private
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Framingham, US HQ
Locations
Menlo Park, US HQ
Dallas, US
Locations
Cambridge, US HQ
Locations
Cambridge, US HQ
Smithfield, US
Locations
South San Francisco, US HQ
Reykjavík, IS
Mocejón, ES
Zug, CH
Aurora, US
New York, US
Thousand Oaks, US
Employees
Employees
18
Employees
85
Employees
96
Employees
17423% increase
Employees
39326% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
13.2 m
Valuation ($)
18.9 m
Valuation ($)
428 m
Twitter followers
Twitter followers
66
Twitter followers
307
Twitter followers
683
Twitter followers
1.6 k
Twitter followers
1.9 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
7
Number of tweets (last 30 days)
4
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
9
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
2.4
Average likes per tweet (last 30 days)
1.3
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
4.7
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
85.71%
Percentage of tweets with engagement (last 30 days)
50%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Alexa Website Rank
Alexa Website Rank
570778
Alexa Website Rank
N/A
Alexa Website Rank
380611
Alexa Website Rank
584094
Alexa Website Rank
296691
Employee Rating
Employee Rating
N/A
Employee Rating
5
Employee Rating
3.6
Employee Rating
4.4
Employee Rating
3.9

Financial

Net income
Net income
N/A
Net income
N/A
Net income
($43.9m) (FY, 2019)
Net income
($196.5m) (FY, 2021)
Net income
($340.1m) (FY, 2021)

Funding

Latest funding round
Latest funding round
$ 3m (almost 5 years ago)
Latest funding round
$ 80m (over 2 years ago)
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
N/A
Total funding raised
Total funding raised
$ 11.2m
Total funding raised
$ 82m
Total funding raised
$ 195m
Total funding raised
$ 245m
Total funding raised
$ 61.8m
For sources of this data, please see the company profile

View company profiles

ReCode Therapeutics
HQ
Menlo Park, US
Employees
85

ReCode Therapeutics is a company developing non-viral nanoparticles for delivery of diverse RNA- and protein-based therapeutics to targeted tissues, and tRNA NanoCorrectors.

View company
Sigilon
HQ
Cambridge, US
Employees
96

Sigilon is a biotechnology company developing functional cures for patients with chronic diseases.

View company
Rubius Therapeutics
HQ
Cambridge, US
Employees
174↑ 23% increase

Rubius is developing a new class of drugs, Red-Cell Therapeutics™.

View company
Atara Biotherapeutics
HQ
South San Francisco, US
Employees
393↑ 26% increase

Atara Biotherapeutics is a drug development company focused on developing innovative therapies for patients with debilitating diseases.

View company